Biofilm antimicrobial susceptibility through an experimental evolutionary lens
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Experimental evolution experiments in which bacterial populations are repeatedly exposed to an antimicrobial treatment, and examination of the genotype and phenotype of the resulting evolved bacteria, can help shed light on mechanisms behind reduced susceptibility. In this review we present an overview of why it is important to include biofilms in experimental evolution, which approaches are available to study experimental evolution in biofilms and what experimental evolution has taught us about tolerance and resistance in biofilms. Finally, we present an emerging consensus view on biofilm antimicrobial susceptibility supported by data obtained during experimental evolution studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“heterogeneity of nutrient and oxygen availability, results in different ecological niches that ensure the formation of distinct subpopulations and, consequently, fixation of beneficial mutations is more easily enabled [78].”
From Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms (2023) · cites this paper as [78]
In the citing paper
“in biofilms under treatment, matrix restrictive penetration results in areas of lower antibiotic concentration that, together with nutrient limitation, can prompt stress responses and lead to mutation emergence [49,78].”
From Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms (2023) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.34 · Cited by 1,612
Definitions and guidelines for research on antibiotic persistence
Balaban, N. Q., Helaine, S., Lewis, K., Ackermann, M., Aldridge, B., Andersson, D. I., Brynildsen, M. P., Bumann, D., Camilli, A., Collins, J. J., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0196-3 · Cited by 1,313
Kawecki, T. J., Lenski, R. E., Ebert, D., Hollis, B., Olivieri, I., & Whitlock, M. C. (2012) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2012.06.001 · Cited by 807
Tseng, B. S., Zhang, W., Harrison, J. J., Quach, T. P., Song, J. L., Penterman, J., Singh, P. K., Chopp, D. L., Packman, A. I., & Parsek, M. R. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12155 · Cited by 466
Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., Riccardi, G., Boon, N., Nelis, H. J., Mahenthiralingam, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058943 · Cited by 135
Self-citation
Research works printed but not linked: 138
- Haas, J. W. The Reverend Dr William Henry Dallinger, F.R.S. (1839–1909). Notes Rec. R. Soc. Lond. 54, 53–65 (2000). · DOI
- Atwood, K. C., Schneider, L. K. & Ryan, F. J. Periodic selection in Escherichia coli. Proc. Natl. Acad. Sci. USA 37, 146–155 (1951). · DOI · Paper page
- Lenski, R. E. Convergence and divergence in a long-term experiment with bacteria. Am. Nat. 190, S57–S68 (2017). · DOI · Paper page
- Lenski, R. E. Experimental evolution and the dynamics of adaptation and genome evolution in microbial populations. ISME J. 11, 2181–2194 (2017). · DOI · Paper page
- Korona, R., Nakatsu, C. H., Forney, L. J. & Lenski, R. E. Evidence for multiple adaptive peaks from populations of bacteria evolving in a structured habitat. Proc. Natl. Acad. Sci. USA 91, 9037–9041 (1994). · DOI · Paper page
- Rainey, P. B. & Travisano, M. Adaptive radiation in a heterogeneous environment. Nature 394, 69–72 (1998). · DOI · Paper page
- Sauer, K. et al. The biofilm life cycle: expanding the conceptual model of biofilm formation. Nat. Rev. Microbiol. 20, 608–620 (2022). · DOI · Paper page
- Stewart, P. S. & Franklin, M. J. Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 6, 199–210 (2008). · DOI · Paper page
- Sonderholm, M. et al. Pseudomonas aeruginosa aggregate formation in an alginate bead model system exhibits in vivo-like characteristics. Appl. Environ. Microbiol. 83, e00113–17 (2017). · DOI · Paper page
- Bjarnsholt, T. et al. The importance of understanding the infectious microenvironment. Lancet Infect. Dis. 22, e88–e92 (2022). · DOI · Paper page
- Ciofu, O., Moser, C., Jensen, P. O. & Hoiby, N. Tolerance and resistance of microbial biofilms. Nat. Rev. Microbiol. 20, 621–635 (2022). · DOI · Paper page
- Livingston, J., Spero, M. A., Lonergan, Z. R. & Newman, D. K. Visualization of mRNA expression in Pseudomonas aeruginosa aggregates reveals spatial patterns of fermentative and denitrifying metabolism. Appl. Environ. Microbiol. 88, e0043922 (2022). · DOI
- Van den Bergh, B., Swings, T., Fauvart, M. & Michiels, J. Experimental design, population Dynamics, and diversity in microbial experimental evolution. Microbiol. Mol. Biol. Rev. 82, e00008–18 (2018). · DOI · Paper page
- Steenackers, H. P., Parijs, I., Dubey, A., Foster, K. R. & Vanderleyden, J. Experimental evolution in biofilm populations. FEMS Microbiol. Rev. 40, 373–397 (2016). · DOI · Paper page
- Habets, M. G., Rozen, D. E., Hoekstra, R. F. & de Visser, J. A. The effect of population structure on the adaptive radiation of microbial populations evolving in spatially structured environments. Ecol. Lett. 9, 1041–1048 (2006). · DOI
- Poltak, S. R. & Cooper, V. S. Ecological succession in long-term experimentally evolved biofilms produces synergistic communities. ISME J. 5, 369–378 (2011). · DOI · Paper page
- Armbruster, C. R. et al. Adaptation and genomic erosion in fragmented Pseudomonas aeruginosa populations in the sinuses of people with cystic fibrosis. Cell Rep. 37, 109829 (2021). · DOI
- Rozen, D. E., Habets, M. G., Handel, A. & de Visser, J. A. Heterogeneous adaptive trajectories of small populations on complex fitness landscapes. PLoS One 3, e1715 (2008). · DOI · Paper page
- Chakraborty, P. P., Nemzer, L. R. & Kassen, R. Experimental evidence that metapopulation structure can accelerate adaptive evolution. bioRxiv https://doi.org/10.1101/2021.07.13.452242 (2021). · doi:10.1101/2021.07.13.452242
- Martens, E. A. & Hallatschek, O. Interfering waves of adaptation promote spatial mixing. Genetics 189, 1045–1060 (2011). · DOI
- Traverse, C. C., Mayo-Smith, L. M., Poltak, S. R. & Cooper, V. S. Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections. Proc. Natl. Acad. Sci. USA 110, E250–E259 (2013). · DOI · Paper page
- Harris, K. B., Flynn, K. M. & Cooper, V. S. Polygenic adaptation and clonal interference enable sustained diversity in experimental pseudomonas aeruginosa populations. Mol. Biol. evolution 38, 5359–5375 (2021). · DOI
- Schick, A. & Kassen, R. Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions. Proc. Natl. Acad. Sci. USA 115, 10714–10719 (2018). · DOI
- Schick, A., Shewaramani, S. & Kassen, R. Genomics of diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions. Genome Biol. Evol. 14, evac074 (2022). · DOI
- Stewart, P. S. Diffusion in biofilms. J. Bacteriol. 185, 1485–1491 (2003). · DOI · Paper page
- Davies, S. K. et al. Visualizing antimicrobials in bacterial biofilms: three-dimensional biochemical imaging using TOF-SIMS. mSphere 2, e00211–17 (2017). · DOI
- Stewart, P. S. et al. Conceptual model of biofilm antibiotic tolerance that integrates phenomena of diffusion, metabolism, gene expression, and physiology. J. Bacteriol. 201, e00307–19 (2019). · DOI · Paper page
- Baquero, F., Negri, M. C., Morosini, M. I. & Blazquez, J. Antibiotic-selective environments. Clin. Infect. Dis. 27, S5–S11 (1998). · DOI · Paper page
- Baquero, F. et al. Evolutionary pathways and trajectories in antibiotic resistance. Clin. Microbiol. Rev. 34, e0005019 (2021). · DOI · Paper page
- Jansen, G., Barbosa, C. & Schulenburg, H. Experimental evolution as an efficient tool to dissect adaptive paths to antibiotic resistance. Drug Resist. Update. 16, 96–107 (2013). · DOI
- Adler, M., Anjum, M., Andersson, D. I. & Sandegren, L. Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli. J. Antimicrobial Chemother. 71, 1188–1198 (2016). · DOI · Paper page
- Langevin, A. M., El Meouche, I. & Dunlop, M. J. Mapping the role of AcrAB-TolC efflux pumps in the evolution of antibiotic resistance reveals near-MIC treatments facilitate resistance acquisition. mSphere 5, e01056–20 (2020). · DOI
- Zhang, G., Wang, C., Sui, Z. & Feng, J. Insights into the evolutionary trajectories of fluoroquinolone resistance in Streptococcus pneumoniae. J. Antimicrobial Chemother. 70, 2499–2506 (2015). · DOI
- Cabot, G. et al. Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates. Antimicrob. Agents Chemother. 60, 1767–1778 (2016). · DOI
- Crabbe, A., Jensen, P. O., Bjarnsholt, T. & Coenye, T. Antimicrobial tolerance and metabolic adaptations in microbial biofilms. Trends Microbiol. 27, 850–863 (2019). · DOI · Paper page
- Stokes, J. M., Lopatkin, A. J., Lobritz, M. A. & Collins, J. J. Bacterial metabolism and antibiotic efficacy. Cell Metab. 30, 251–259 (2019). · DOI · Paper page
- Zampieri, M. et al. Metabolic constraints on the evolution of antibiotic resistance. Mol. Syst. Biol. 13, 917 (2017). · DOI · Paper page
- Lopatkin, A. J. et al. Clinically relevant mutations in core metabolic genes confer antibiotic resistance. Science 371, eaba0862 (2021). · DOI · Paper page
- Van Acker, H. & Coenye, T. The role of reactive oxygen species in antibiotic-mediated killing of bacteria. Trends Microbiol. 25, 456–466 (2017). · DOI · Paper page
- Meylan, S., Andrews, I. W. & Collins, J. J. Targeting antibiotic tolerance, pathogen by pathogen. Cell 172, 1228–1238 (2018). · DOI · Paper page
- Kester, J. C. & Fortune, S. M. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria. Crit. Rev. Biochem. Mol. Biol. 49, 91–101 (2014). · DOI · Paper page
- Windels, E. M., Van den Bergh, B. & Michiels, J. Bacteria under antibiotic attack: different strategies for evolutionary adaptation. PLoS Pathog. 16, e1008431 (2020). · DOI
- Verstraete, L., Van den Bergh, B., Verstraeten, N. & Michiels, J. Ecology and evolution of antibiotic persistence. Trends Microbiol. 30, 466–479 (2022). · DOI
- Fridman, O., Goldberg, A., Ronin, I., Shoresh, N. & Balaban, N. Q. Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature 513, 418–421 (2014). · DOI · Paper page
- Dengler Haunreiter, V. et al. In-host evolution of Staphylococcus epidermidis in a pacemaker-associated endocarditis resulting in increased antibiotic tolerance. Nat. Commun. 10, 1149 (2019). · DOI
- Jennings, L. K. et al. Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies. Cell Rep. 34, 108782 (2021). · DOI · Paper page
- Chakraborty, P., Bajeli, S., Kaushal, D., Radotra, B. D. & Kumar, A. Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis. Nat. Commun. 12, 1606 (2021). · DOI · Paper page
- Sonderholm, M. et al. The consequences of being in an infectious biofilm: microenvironmental conditions governing antibiotic tolerance. Int. J. Mol. Sci. 18, 2688 (2017). · DOI
- Rossi, E. et al. Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat. Rev. Microbiol. 19, 331–342 (2021). · DOI · Paper page
- Michiels, J. E., Van den Bergh, B., Verstraeten, N., Fauvart, M. & Michiels, J. In vitro emergence of high persistence upon periodic aminoglycoside challenge in the ESKAPE pathogens. Antimicrob. Agents Chemother. 60, 4630–4637 (2016). · DOI
- Van den Bergh, B. et al. Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nat. Microbiol. 1, 16020 (2016). · DOI · Paper page
- Levin-Reisman, I. et al. Antibiotic tolerance facilitates the evolution of resistance. Science 355, 826–830 (2017). · DOI · Paper page
- Santi, I., Manfredi, P., Maffei, E., Egli, A. & Jenal, U. Evolution of antibiotic tolerance shapes resistance development in chronic Pseudomonas aeruginosa infections. mBio 12, e03482–20 (2021). · DOI · Paper page
- Sebastian, J. et al. De Novo emergence of genetically resistant mutants of Mycobacterium tuberculosis from the persistence phase cells formed against antituberculosis drugs in vitro. Antimicrob. Agents Chemother. 61, e01343–16 (2017). · DOI · Paper page
- Vogwill, T., Comfort, A. C., Furio, V. & MacLean, R. C. Persistence and resistance as complementary bacterial adaptations to antibiotics. J. Evolut. Biol. 29, 1223–1233 (2016). · DOI
- Windels, E. M. et al. Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates. ISME J. 13, 1239–1251 (2019). · DOI · Paper page
- Coenye, T. & Nelis, H. J. In vitro and in vivo model systems to study microbial biofilm formation. J. Microbiol. Methods 83, 89–105 (2010). · DOI · Paper page
- Azeredo, J. et al. Critical review on biofilm methods. Crit. Rev. Microbiol. 43, 313–351 (2017). · DOI · Paper page
- Mai-Prochnow, H. K. N. V. B. X. A. Clinically relevant in vitro biofilm models: a need to mimic and recapitulate the host environment. Biofilm 4, 100069 (2022). · DOI
- Lebeaux, D., Chauhan, A., Rendueles, O. & Beloin, C. From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens. 2, 288–356 (2013). · DOI · Paper page
- Cooper, V. S., Staples, R. K., Traverse, C. C. & Ellis, C. N. Parallel evolution of small colony variants in Burkholderia cenocepacia biofilms. Genomics 104, 447–452 (2014). · DOI
- O’Rourke, D., FitzGerald, C. E., Traverse, C. C. & Cooper, V. S. There and back again: consequences of biofilm specialization under selection for dispersal. Front. Genet. 6, 18 (2015).
- Martin, M., Holscher, T., Dragos, A., Cooper, V. S. & Kovacs, A. T. Laboratory evolution of microbial interactions in bacterial biofilms. J. Bacteriol. 198, 2564–2571 (2016). · DOI
- Santos-Lopez, A., Marshall, C. W., Scribner, M. R., Snyder, D. J. & Cooper, V. S. Evolutionary pathways to antibiotic resistance are dependent upon environmental structure and bacterial lifestyle. eLife 8, e47612 (2019). · DOI · Paper page
- Sass, A. et al. Various evolutionary trajectories lead to loss of the tobramycin-potentiating activity of the Quorum-sensing inhibitor baicalin hydrate in Burkholderia cenocepacia biofilms. Antimicrob. Agents Chemother. 63, e02092–18 (2019). · DOI
- Oakley, J. L. et al. Phenotypic and genotypic adaptations in Pseudomonas aeruginosa biofilms following long-term exposure to an alginate oligomer therapy. mSphere 6, e01216–20 (2021). · DOI
- Trampari, E. et al. Exposure of Salmonella biofilms to antibiotic concentrations rapidly selects resistance with collateral tradeoffs. NPJ biofilms microbiomes 7, 3 (2021). · DOI · Paper page
- Scribner, M. R., Santos-Lopez, A., Marshall, C. W., Deitrick, C. & Cooper, V. S. Parallel evolution of tobramycin resistance across species and environments. mBio 11, e00932–20 (2020). · DOI · Paper page
- Ahmed, M. N., Porse, A., Sommer, M. O. A., Hoiby, N. & Ciofu, O. Evolution of antibiotic resistance in biofilm and planktonic Pseudomonas aeruginosa populations exposed to subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 62, e00320–18 (2018). · DOI · Paper page
- Ahmed, M. N. et al. Lack of the major multifunctional catalase KatA in Pseudomonas aeruginosa accelerates evolution of antibiotic resistance in ciprofloxacin-treated biofilms. Antimicrob. Agents Chemother. 63, e00766–19 (2019). · DOI
- Maiden, M. M. & Waters, C. M. Triclosan depletes the membrane potential in Pseudomonas aeruginosa biofilms inhibiting aminoglycoside induced adaptive resistance. PLoS Pathog. 16, e1008529 (2020). · DOI
- Zaborskyte, G., Wistrand-Yuen, E., Hjort, K., Andersson, D. I. & Sandegren, L. Modular 3D-printed Peg biofilm device for flexible setup of surface-related biofilm studies. Front. Cell. Infect. Microbiol. 11, 802303 (2021). · DOI
- Hjort, K., Fermer, E., Tang, P. C. & Andersson, D. I. Antibiotic minimal selective concentrations and fitness costs during biofilm and planktonic growth. mBio 13, e0144722 (2022). · DOI
- France, M. T., Cornea, A., Kehlet-Delgado, H. & Forney, L. J. Spatial structure facilitates the accumulation and persistence of antibiotic-resistant mutants in biofilms. Evolut. Appl. 12, 498–507 (2019). · DOI · Paper page
- Miller, C. et al. Adaptation of Enterococcus faecalis to daptomycin reveals an ordered progression to resistance. Antimicrob. Agents Chemother. 57, 5373–5383 (2013). · DOI · Paper page
- Hammerstrom, T. G., Beabout, K., Clements, T. P., Saxer, G. & Shamoo, Y. Acinetobacter baumannii repeatedly evolves a hypermutator phenotype in response to tigecycline that effectively surveys evolutionary trajectories to resistance. PLoS One 10, e0140489 (2015). · DOI
- Mehta, H. H., Prater, A. G. & Shamoo, Y. Using experimental evolution to identify druggable targets that could inhibit the evolution of antimicrobial resistance. J. Antibiotics 71, 279–286 (2018). · DOI
- Zhang, Q. et al. Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science 333, 1764–1767 (2011). · DOI · Paper page
- Zoheir, A. E., Spath, G. P., Niemeyer, C. M. & Rabe, K. S. Microfluidic evolution-on-a-chip reveals new mutations that cause antibiotic resistance. Small 17, e2007166 (2021). · DOI
- Tang, P. C. et al. A microfluidic chip for studies of the dynamics of antibiotic resistance selection in bacterial biofilms. Front. Cell. Infect. Microbiol. 12, 896149 (2022). · DOI
- Palmer, K. L., Aye, L. M. & Whiteley, M. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189, 8079–8087 (2007). · DOI · Paper page
- Wong, A., Rodrigue, N. & Kassen, R. Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa. PLoS Genet. 8, e1002928 (2012). · DOI · Paper page
- Bove, M., Bao, X., Sass, A., Crabbe, A. & Coenye, T. The Quorum-sensing inhibitor furanone C-30 rapidly loses its tobramycin-potentiating activity against Pseudomonas aeruginosa biofilms during experimental evolution. Antimicrob. Agents Chemother. 65, e0041321 (2021). · DOI
- Drlica, K. & Zhao, X. Mutant selection window hypothesis updated. Clin. Infect. Dis. 44, 681–688 (2007). · DOI · Paper page
- Trubenova, B., Roizman, D., Moter, A., Rolff, J. & Regoes, R. R. Population genetics, biofilm recalcitrance, and antibiotic resistance evolution. Trends Microbiol. 30, 841–852 (2022). · DOI
- Sanz-Garcia, F., Sanchez, M. B., Hernando-Amado, S. & Martinez, J. L. Evolutionary landscapes of Pseudomonas aeruginosa towards ribosome-targeting antibiotic resistance depend on selection strength. Int. J. antimicrobial agents 55, 105965 (2020). · DOI
- Barrick, J. E. & Lenski, R. E. Genome dynamics during experimental evolution. Nat. Rev. Genet. 14, 827–839 (2013). · DOI · Paper page
- Bos, A. C., Passe, K. M., Mouton, J. W., Janssens, H. M. & Tiddens, H. A. The fate of inhaled antibiotics after deposition in cystic fibrosis: How to get drug to the bug? J. Cyst. Fibros. 16, 13–23 (2017). · doi:10.1016/j.jcf.2016.10.001
- van Os, W. & Zeitlinger, M. Predicting antimicrobial activity at the target site: pharmacokinetic/pharmacodynamic indices versus time-kill approaches. Antibiotics 10, 1485 (2021). · DOI
- Cao, B. et al. Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model. J. Antimicrobial Chemother. 70, 2057–2063 (2015). · DOI · Paper page
- Christophersen, L. et al. In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments. J. Cyst. Fibros. 19, 996–1003 (2020). · DOI · Paper page
- Messiaen, A. S., Forier, K., Nelis, H., Braeckmans, K. & Coenye, T. Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms. PLoS One 8, e79220 (2013). · DOI
- Dwyer, D. J., Kohanski, M. A. & Collins, J. J. Role of reactive oxygen species in antibiotic action and resistance. Curr. Opin. Microbiol. 12, 482–489 (2009). · DOI · Paper page
- Zheng, E. J., Stokes, J. M. & Collins, J. J. Eradicating bacterial persisters with combinations of strongly and weakly metabolism-dependent antibiotics. Cell Chem. Biol. 27, 1544–1552.e1543 (2020). · DOI
- Zheng, E. J. et al. Modulating the evolutionary trajectory of tolerance using antibiotics with different metabolic dependencies. Nat. Commun. 13, 2525 (2022). · DOI
- Davies, E. V., James, C. E., Brockhurst, M. A. & Winstanley, C. Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model. BMC Microbiol. 17, 3 (2017). · DOI
- Usui, M., Yoshii, Y., Thiriet-Rupert, S., Ghigo, J.-M. & Beloin, C. Intermittent antibiotic treatment of bacterial biofilms favors the rapid evolution of resistance. bioRxiv https://doi.org/10.1101/2022.05.03.490405 (2022). · DOI
- Hansen, S. K., Rainey, P. B., Haagensen, J. A. & Molin, S. Evolution of species interactions in a biofilm community. Nature 445, 533–536 (2007). · DOI · Paper page
- Tognon, M. et al. Co-evolution with Staphylococcus aureus leads to lipopolysaccharide alterations in Pseudomonas aeruginosa. ISME J. 11, 2233–2243 (2017). · DOI
- Vandeplassche, E. et al. In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members. Sci. Rep. 9, 12859 (2019). · DOI
- Cairns, J., Jokela, R., Becks, L., Mustonen, V. & Hiltunen, T. Repeatable ecological dynamics govern the response of experimental communities to antibiotic pulse perturbation. Nat. Ecol. Evol. 4, 1385–1394 (2020). · DOI
- Cooper, V. S. et al. Experimental evolution in vivo to identify selective pressures during pneumococcal colonization. mSystems 5, e00352–20 (2020). · DOI
- Lebov, J. F., Schlomann, B. H., Robinson, C. D. & Bohannan, B. J. M. Phenotypic parallelism during experimental adaptation of a free-living bacterium to the zebrafish gut. mBio 11, e01519–20 (2020). · DOI
- Bove, M. & Coenye, T. The anti-virulence activity of the non-mevalonate pathway inhibitor FR900098 towards Burkholderia cenocepacia is maintained during experimental evolution. Microbiology 168, 001170 (2022). · doi:10.1099/mic.0.001170
- Thoming, J. G. et al. Parallel evolutionary paths to produce more than one Pseudomonas aeruginosa biofilm phenotype. NPJ Biofilms Microbiomes 6, 2 (2020). · DOI
- Thoming, J. G. & Haussler, S. Pseudomonas aeruginosa is more tolerant under biofilm than under planktonic growth conditions: a multi-isolate survey. Front. Cell. Infect. Microbiol. 12, 851784 (2022). · DOI
- Tyerman, J. G., Ponciano, J. M., Joyce, P., Forney, L. J. & Harmon, L. J. The evolution of antibiotic susceptibility and resistance during the formation of Escherichia coli biofilms in the absence of antibiotics. BMC Evolut. Biol. 13, 22 (2013). · DOI
- Azimi, S. et al. Allelic polymorphism shapes community function in evolving Pseudomonas aeruginosa populations. ISME J. 14, 1929–1942 (2020). · DOI · Paper page
- Allegrucci, M. & Sauer, K. Formation of Streptococcus pneumoniae non-phase-variable colony variants is due to increased mutation frequency present under biofilm growth conditions. J. Bacteriol. 190, 6330–6339 (2008). · DOI · Paper page
- Boles, B. R., Thoendel, M. & Singh, P. K. Self-generated diversity produces “insurance effects” in biofilm communities. Proc. Natl. Acad. Sci. USA 101, 16630–16635 (2004). · DOI · Paper page
- Ryder, V. J., Chopra, I. & O’Neill, A. J. Increased mutability of Staphylococci in biofilms as a consequence of oxidative stress. PLoS One 7, e47695 (2012). · DOI
- Shewaramani, S. et al. Anaerobically grown Escherichia coli has an enhanced mutation rate and distinct mutational spectra. PLoS Genet. 13, e1006570 (2017). · DOI
- Maharjan, R. P. & Ferenci, T. A shifting mutational landscape in 6 nutritional states: Stress-induced mutagenesis as a series of distinct stress input-mutation output relationships. PLoS Biol. 15, e2001477 (2017). · DOI
- Ahmed, M. N. et al. The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance. NPJ biofilms microbiomes 6, 28 (2020). · DOI · Paper page
- Boles, B. R. & Singh, P. K. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc. Natl. Acad. Sci. USA 105, 12503–12508 (2008). · DOI · Paper page
- Santos-Lopez, A. et al. Evolved resistance to a novel cationic peptide antibiotic requires high mutation supply. Evol. Med. Public Health 10, 266–276 (2022). · DOI
- Penesyan, A., Nagy, S. S., Kjelleberg, S., Gillings, M. R. & Paulsen, I. T. Rapid microevolution of biofilm cells in response to antibiotics. NPJ biofilms microbiomes 5, 34 (2019). · DOI · Paper page
- Van Acker, H., Van Dijck, P. & Coenye, T. Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol. 22, 326–333 (2014). · DOI · Paper page
- Hibbing, M. E., Fuqua, C., Parsek, M. R. & Peterson, S. B. Bacterial competition: surviving and thriving in the microbial jungle. Nat. Rev. Microbiol. 8, 15–25 (2010). · DOI · Paper page
- Trampari, E. et al. Cefotaxime exposure selects mutations within the CA-domain of envZ which promote antibiotic resistance but repress biofilm formation in Salmonella. Microbiol. Spectr. 10, e0214521 (2022). · DOI
- Wong, A. & Kassen, R. Parallel evolution and local differentiation in quinolone resistance in Pseudomonas aeruginosa. Microbiol. (Read., Engl.) 157, 937–944 (2011). · DOI
- Eklof, J. et al. Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease. Clin. Microbiol. Infect. 28, 990–995 (2022). · DOI
- Kolpen, M. et al. Bacterial biofilms predominate in both acute and chronic human lung infections. Thorax 77, 1015–1022 (2022). · DOI · Paper page
- Laborda, P., Martinez, J. L. & Hernando-Amado, S. Evolution of Habitat-Dependent Antibiotic Resistance in Pseudomonas aeruginosa. Microbiol. Spectrum 10, e0024722 (2022). · DOI
- Stewart, P. S. et al. Search for a Shared Genetic or Biochemical Basis for Biofilm Tolerance to Antibiotics across Bacterial Species. Antimicrob. Agents Chemother. 66, e0002122 (2022). · DOI
- Schroeder, J. W., Yeesin, P., Simmons, L. A. & Wang, J. D. Sources of spontaneous mutagenesis in bacteria. Crit. Rev. Biochem. Mol. Biol. 53, 29–48 (2018). · DOI · Paper page
- Oliver, A., Canton, R., Campo, P., Baquero, F. & Blazquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251–1254 (2000). · DOI · Paper page
- Mena, A. et al. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J. Bacteriol. 190, 7910–7917 (2008). · DOI · Paper page
- Oliver, A. & Mena, A. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin. Microbiol. Infect. 16, 798–808 (2010). · DOI · Paper page
- Driffield, K., Miller, K., Bostock, J. M., O’Neill, A. J. & Chopra, I. Increased mutability of Pseudomonas aeruginosa in biofilms. J. Antimicrobial Chemother. 61, 1053–1056 (2008). · DOI · Paper page
- Perez-Osorio, A. C., Williamson, K. S. & Franklin, M. J. Heterogeneous rpoS and rhlR mRNA levels and 16S rRNA/rDNA (rRNA gene) ratios within Pseudomonas aeruginosa biofilms, sampled by laser capture microdissection. J. Bacteriol. 192, 2991–3000 (2010). · DOI
- Brown, M. R., Allison, D. G. & Gilbert, P. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J. Antimicrobial Chemother. 22, 777–780 (1988). · DOI · Paper page
- Molin, S. & Tolker-Nielsen, T. Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr. Opin. Biotechnol. 14, 255–261 (2003). · DOI · Paper page
- Madsen, J. S., Burmolle, M., Hansen, L. H. & Sorensen, S. J. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol. Med. Microbiol. 65, 183–195 (2012). · DOI · Paper page
- Krol, J. E. et al. Increased transfer of a multidrug resistance plasmid in Escherichia coli biofilms at the air-liquid interface. Appl. Environ. Microbiol. 77, 5079–5088 (2011). · DOI
- Krol, J. E. et al. Invasion of E. coli biofilms by antibiotic resistance. Plasmids. Plasmid 70, 110–119 (2013). · DOI
- Bender, N., Hennes, M. & Maier, B. Mobility of extracellular DNA within gonococcal colonies. Biofilm 4, 100078 (2022). · DOI
- Merod, R. T. & Wuertz, S. Extracellular polymeric substance architecture influences natural genetic transformation of Acinetobacter baylyi in biofilms. Appl. Environ. Microbiol. 80, 7752–7757 (2014). · DOI
Cited by
Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms
Fernández-Billón, M., Llambías-Cabot, A. E., Jordana-Lluch, E., Oliver, A., & Macià, M. D. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100129 · Cited by 170
Metadata
- Authors
- Coenye, T., Bové, M., & Bjarnsholt, T.
- Venue
- npj Biofilms and Microbiomes
- Published
- 2022-10-18
- Volume
- 8
- Issue
- 1
- ISSN
- 2055-5008
- Cited by
- 62
- References
- 7
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Lundbeckfonden (R364-2021-1474)
- Fonds Wetenschappelijk Onderzoek (V401322N)
- Bijzonder Onderzoeksfonds (BOF.DOC.2018.0023.01)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biofilm antimicrobial susceptibility through an experimental evolutionary lens. https://app.cochat.ai/papers/10.1038/s41522-022-00346-4
- The paper
- Coenye, T., Bové, M., & Bjarnsholt, T. (2022). Biofilm antimicrobial susceptibility through an experimental evolutionary lens. npj Biofilms and Microbiomes. https://doi.org/10.1038/s41522-022-00346-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.